{
    "root": "303cb0b2-9e45-d4c3-e063-6394a90ac8cc",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Acyclovir",
    "value": "20250313",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POVIDONE",
            "code": "FZ989GH94E",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11061"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "ACYCLOVIR",
            "code": "X4HES1O11F",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_2453"
        }
    ],
    "indications": {
        "text": "herpes zoster infections : acyclovir tablets , usp indicated acute treatment herpes zoster ( shingles ) . genital herpes : acyclovir tablets , usp indicated treatment initial episodes management recurrent episodes genital herpes . chickenpox : acyclovir tablets , usp indicated treatment chickenpox ( varicella ) .",
        "doid_entities": [
            {
                "text": "herpes zoster (DOID:8536)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8536"
            },
            {
                "text": "genital herpes (DOID:8704)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8704"
            },
            {
                "text": "chickenpox (DOID:8659)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8659"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "acute treatment herpes zoster : 800 mg every 4 hours orally , 5 times daily 7 10 days . genital herpes : treatment initial genital herpes : 200 mg every 4 hours , 5 times daily 10 days . chronic suppressive therapy recurrent disease : 400 mg 2 times daily 12 months , followed re-evaluation . alternative regimens included doses ranging 200 mg 3 times daily 200 mg 5 times daily . frequency severity episodes untreated genital herpes may change time . 1 year therapy , frequency severity patient \u2019 genital herpes infection re-evaluated assess need continuation therapy acyclovir tablets . intermittent therapy : 200 mg every 4 hours , 5 times daily 5 days . therapy initiated earliest sign symptom ( prodrome ) recurrence . treatment chickenpox : children ( 2 years age older ) : 20 mg/kg per dose orally 4 times daily ( 80 mg/kg/day ) 5 days . children 40 kg receive adult dose chickenpox . adults children 40 kg : 800 mg 4 times daily 5 days . intravenous acyclovir indicated treatment varicella-zoster infections immunocompromised patients . therapy indicated , initiated earliest sign symptom chickenpox . information efficacy therapy initiated 24 hours onset signs symptoms . patients acute chronic renal impairment : patients renal impairment , dose acyclovir tablets modified shown table 3. table 3. modification renal impairment normal regimen creatinine clearance ( ml/min/1.73 2 ) adjusted regimen dose ( mg ) dosing interval 200 mg every 4 hours > 10 0-10 200 200 every 4 hours , 5x daily every 12 hours 400 mg every 12 hours > 10 0-10 400 200 every 12 hours every 12 hours 800 mg every 4 hours > 25 10-25 0-10 800 800 800 every 4 hours , 5x daily every 8 hours every 12 hours hemodialysis : patients require hemodialysis , mean plasma half-life acyclovir hemodialysis approximately 5 hours . results 60 % decrease plasma concentrations following 6-hour dialysis period . therefore , patient \u2019 dosing schedule adjusted additional dose administered dialysis . peritoneal dialysis : supplemental dose appears necessary adjustment dosing interval .",
        "doid_entities": [
            {
                "text": "herpes zoster (DOID:8536)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8536"
            },
            {
                "text": "genital herpes (DOID:8704)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8704"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            },
            {
                "text": "chickenpox (DOID:8659)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8659"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "acute chronic renal",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_98255"
            }
        ]
    },
    "warningsAndPrecautions": "acyclovir tablets usp , 400 mg containing 400 mg acyclovir usp pink , shield shaped , flat tablets debossed ' j ' one side '49 ' triangle . supplied follows : ndc : 70518-2455-00 ndc : 70518-2455-01 ndc : 70518-2455-02 ndc : 70518-2455-03 ndc : 70518-2455-04 packaging : 30 1 blister pack packaging : 15 1 bottle plastic packaging : 30 1 bottle plastic packaging : 21 1 bottle plastic packaging : 50 1 bottle plastic store 15\u00ba 25\u00bac . protect light moisture . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "acyclovir tablets contraindicated patients develop hypersensitivity acyclovir valacyclovir .",
    "indications_original": "Herpes Zoster Infections: Acyclovir tablets, USP are indicated for the acute treatment of herpes zoster (shingles).\n       \n \n  \n       \n \n  \n                     Genital Herpes: Acyclovir tablets, USP are indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes.\n       \n \n  \n       \n \n  \n                     Chickenpox: Acyclovir tablets, USP are indicated for the treatment of chickenpox (varicella).",
    "contraindications_original": "Acute Treatment of Herpes Zoster: 800 mg every 4 hours orally, 5 times daily for 7 to 10 days.\n       \n \n  \n       \n \n  \n                     Genital Herpes: \n        \n  \n   \n        \n  \n   Treatment of Initial Genital Herpes:\n                      200 mg every 4 hours, 5 times daily for 10 days.\n       \n \n  \n       \n \n  \n                     \n                        Chronic Suppressive Therapy for Recurrent Disease:\n                      400 mg 2 times daily for up to 12 months, followed by re-evaluation. Alternative regimens have included doses ranging from 200 mg 3 times daily to 200 mg 5 times daily.\n       \n \n  \n       \n \n   The frequency and severity of episodes of untreated genital herpes may change over time. After 1 year of therapy, the frequency and severity of the patient\u2019s genital herpes infection should be re-evaluated to assess the need for continuation of therapy with acyclovir tablets.\n       \n \n  \n       \n \n  \n                     \n                        Intermittent Therapy:\n                      200 mg every 4 hours, 5 times daily for 5 days. Therapy should be initiated at the earliest sign or symptom (prodrome) of recurrence.\n       \n \n  \n       \n \n  \n                     Treatment of Chickenpox: Children (2 years of age and older): 20 mg/kg per dose orally 4 times daily (80 mg/kg/day) for 5 days. Children over 40 kg should receive the adult dose for chickenpox.\n       \n \n  \n       \n \n  \n                     \n                        Adults and Children over 40 kg:\n                     \u00a0 800 mg 4 times daily for 5 days. \n       \n \n  \n       \n \n   Intravenous acyclovir is indicated for the treatment of varicella-zoster infections in immunocompromised patients.\n       \n \n  \n       \n \n   When therapy is indicated, it should be initiated at the earliest sign or symptom of chickenpox. There is no information about the efficacy of therapy initiated more than 24 hours after onset of signs and symptoms.\n       \n \n  \n       \n \n  \n                     Patients With Acute or Chronic Renal Impairment: In patients with renal impairment, the dose of acyclovir tablets should be modified as shown in Table 3.\n       \n \n  \n       \n \n  \n                     Table 3. Dosage Modification for Renal Impairment\u00a0 \n      \n\n \n      \n\n \n                  \n                  \n                     \n                        \n                           \n                              Normal Dosage Regimen\n         \n   \n    \n         \n   \n    \n                           \n                              Creatinine Clearance\n          \n    \n     \n          \n    \n     (mL/min/1.73 m\n          \n    \n     \n          \n    \n     2)\n                           \n                           \n                              Adjusted Dosage Regimen\n         \n   \n    \n         \n   \n    \n                        \n                        \n                           \n                              Dose (mg)\n         \n   \n    \n         \n   \n    \n                           \n                              Dosing Interval\n         \n   \n    \n         \n   \n    \n                        \n                        \n                           200 mg every 4 hours\n          \n    \n     \n          \n    \n     \n                           \n                           \n                              > 10\n          \n    \n     \n          \n    \n     0-10\n         \n   \n    \n         \n   \n    \n                           \n                              200\n          \n    \n     \n          \n    \n                  \u00a0200\u00a0\n         \n   \n    \n         \n   \n    \n                           \n                              every 4 hours, 5x daily\n          \n    \n     \n          \n    \n     every 12 hours\n         \n   \n    \n         \n   \n    \n                        \n                        \n                           \n                              400 mg every 12 hours\n         \n   \n    \n         \n   \n    \n                           \n                              > 10\n          \n    \n     \n          \n    \n     0-10\n         \n   \n    \n         \n   \n    \n                           \n                              400\n          \n    \n     \n          \n    \n                  \u00a0200\u00a0\n         \n   \n    \n         \n   \n    \n                           \n                              every 12 hours\n          \n    \n     \n          \n    \n     \n                              every 12 hours\n         \n   \n    \n         \n   \n    \n                        \n                        \n                           800 mg every 4 hours\n                           \n                              > 25\n          \n    \n     \n          \n    \n     10-25\n          \n    \n     \n          \n    \n     0-10\n         \n   \n    \n         \n   \n    \n                           \n                              800\n          \n    \n     \n          \n    \n                  800\n          \n    \n     \n          \n    \n                  800\n         \n   \n    \n         \n   \n    \n                           \n                              every 4 hours, 5x daily\n          \n    \n     \n          \n    \n     every 8 hours\n          \n    \n     \n          \n    \n     \n                              every 12 hours\n         \n   \n    \n         \n   \n    \n                        \n                     \n                  \n                  \n                     \u00a0\n                     \n                     Hemodialysis: For patients who require hemodialysis, the mean plasma half-life of acyclovir during hemodialysis is approximately 5 hours. This results in a 60% decrease in plasma concentrations following a 6-hour dialysis period. Therefore, the patient\u2019s dosing schedule should be adjusted so that an additional dose is administered after each dialysis.\n       \n \n  \n       \n \n  \n                     Peritoneal Dialysis: No supplemental dose appears to be necessary after adjustment of the dosing interval.",
    "warningsAndPrecautions_original": "Acyclovir tablets USP, 400 mg containing 400 mg of acyclovir USP are pink, shield shaped, flat tablets debossed with 'J' on one side and '49' in triangle on the other. They are supplied as follows:\n                  NDC: 70518-2455-00\n                  NDC: 70518-2455-01\n                  NDC: 70518-2455-02\n                  NDC: 70518-2455-03\n                  NDC: 70518-2455-04\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 15 in 1 BOTTLE PLASTIC\n                  PACKAGING: 30 in 1 BOTTLE PLASTIC\n                  PACKAGING: 21 in 1 BOTTLE PLASTIC\n                  PACKAGING: 50 in 1 BOTTLE PLASTIC\n                  \n                  Store between 15\u00ba and 25\u00baC. Protect from light and moisture.\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Acyclovir tablets are contraindicated for patients who develop hypersensitivity to acyclovir or valacyclovir.",
    "drug": [
        {
            "name": "Acyclovir",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_2453"
        }
    ]
}